Investors Press Releases Nov 09 2026 Tiziana KOL Call Highlights Consistency Between Positive Phase 2a INFORM-MS Topline Results and Longer-Term Clinical Benefits Observed in Expanded Access Program for Patients with Non-Active Secondary Progressive Multiple Sclerosis Treated with Intranasal Foralumab Read More Nov 09 2026 Tiziana Life Sciences to Present at BIO-Europe 2026 and Host KOL Webcast Read More Nov 05 2026 Tiziana to Host Investor Call with Key Opinion Leaders to Discuss Positive Phase 2a INFORM-MS Topline Results Read More btn News View All Events & Presentations Nov 09 2026 at 12:00 PM EST Nov 09 2026 at 12:00 PM EST Intranasal Foralumab INFORM-MS KOL Webcast Read More btn Events View All Interim Reports Interim Results for the Six Months Ended 30 June 2026 758.9 KB bth Interim Reports View All Annual Reports 20 F - Annual Report for the year ended 31 December 2025 2 MB btn ARs View All Annual General Meeting 2025 AGM Results 60.5 KB btn AGM View All Stock Quote Change Volume Today's Open Previous Close Today's High Today's Low 52 Week High 52 Week Low Stock Chart
Nov 09 2026 Tiziana KOL Call Highlights Consistency Between Positive Phase 2a INFORM-MS Topline Results and Longer-Term Clinical Benefits Observed in Expanded Access Program for Patients with Non-Active Secondary Progressive Multiple Sclerosis Treated with Intranasal Foralumab Read More
Nov 05 2026 Tiziana to Host Investor Call with Key Opinion Leaders to Discuss Positive Phase 2a INFORM-MS Topline Results Read More
Nov 09 2026 at 12:00 PM EST Nov 09 2026 at 12:00 PM EST Intranasal Foralumab INFORM-MS KOL Webcast Read More